5-HT1-like receptor agonists and the pathophysiology of migraine
- 31 May 1989
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (5) , 200-204
- https://doi.org/10.1016/0165-6147(89)90238-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Can the vascular and neurogenic theories of migraine finally be reconciled?Trends in Pharmacological Sciences, 1989
- Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headachesAnnals of Neurology, 1988
- Further characterization of 5‐hydroxytryptamine1‐like receptors mediating tachycardia in the cat: No apparent relationship to known subtypes of the 5‐hydroxytryptamine1 binding siteDrug Development Research, 1988
- Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological AnalysisJournal of Cardiovascular Pharmacology, 1987
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- Clinical Pharmacokinetics of Ergotamine in Migraine and Cluster HeadacheClinical Pharmacokinetics, 1985
- Extracranial vascular changes and the source of pain in migraine headacheAnnals of Neurology, 1983
- A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous veinJournal of Pharmacy and Pharmacology, 1981
- Selective vasoconstriction in carotid vascular bed by methysergide: Possible relevance to its antimigraine effectEuropean Journal of Pharmacology, 1974
- ROLE OF SOME BIOGENIC SUBSTANCES IN MIGRAINE AND RELEVANT MECHANISM IN ANTIMIGRAINE ACTION OF ERGOTAMINE‐STUDIES IN AN EXPERIMENTAL MODEL FOR MIGRAINEHeadache: The Journal of Head and Face Pain, 1974